Nyxoah SA (EBR:NYXH)

Belgium flag Belgium · Delayed Price · Currency is EUR
4.475
+0.080 (1.82%)
Last updated: Oct 29, 2025, 11:01 AM CET
1.82%
Market Cap166.96M
Revenue (ttm)4.93M
Net Income (ttm)-77.20M
Shares Out37.44M
EPS (ttm)-2.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume6,885
Average Volume125,578
Open4.520
Previous Close4.395
Day's Range4.375 - 4.520
52-Week Range3.840 - 11.150
Beta0.58
RSI40.20
Earnings DateNov 13, 2025

About Nyxoah

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. [Read more]

Sector Healthcare
Founded 2009
Employees 184
Stock Exchange Euronext Brussels
Ticker Symbol NYXH
Full Company Profile

Financial Performance

In 2024, Nyxoah's revenue was 4.52 million, an increase of 3.98% compared to the previous year's 4.35 million. Losses were -59.24 million, 37.1% more than in 2023.

Financial Statements

News

There is no news available yet.